Behzad Molavi
Department of Internal Medicine
Division of Cardiovascular Medicine
University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System
Little Rock
USA
Name/email consistency: high
- Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. Molavi, B., Chen, J., Mehta, J.L. Am. J. Physiol. Heart Circ. Physiol. (2006)
- The prevention and treatment of metabolic syndrome and high-risk obesity. Molavi, B., Rasouli, N., Kern, P.A. Curr. Opin. Cardiol. (2006)
- Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Molavi, B., Mehta, J.L. Curr. Opin. Cardiol. (2004)